Effect of Ergocalciferol on β-Cell Function in New-Onset Type 1 Diabetes A Secondary Analysis of a Randomized Clinical Trial

被引：0
|
作者：
Nwosu, Benjamin Udoka [1 ,2 ]
Parajuli, Sadichchha [2 ,3 ]
Sharma, Rohit B. [4 ]
Lee, Austin F. [5 ]
机构：
[1] Northwell Hlth, Cohen Childrens Med Ctr, Dept Pediat, Div Endocrinol, New Hyde Pk, NY USA
[2] Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA USA
[3] Louisiana State Univ Hosp, Monroe Family Med Program, Shreveport, LA USA
[4] Weill Cornell Med, Div Endocrinol Diabet & Metab, Dept Med, New York, NY USA
[5] Univ Massachusetts, Chan Med Sch, Dept Populat & Quantitat Hlth Sci, Worcester, MA 01605 USA
来源：
JAMA NETWORK OPEN | 2024年 / 7卷 / 03期
关键词：
D O I：
10.1001/jamanetworkopen.2024.1155
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This secondary analysis of a randomized clinical trial evaluates the effectiveness of ergocalciferol vs placebo in youths with newly diagnosed type 1 diabetes.
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Comparison of Clinical Profiles of New-Onset Diabetes in Pancreatic Cancer (PaC) and New-Onset Type 2 DM
    Kamada, P.
    Rabe, K.
    Srinivasan, S.
    Chari, S. T.
    PANCREAS, 2009, 38 (08) : 1011 - 1012
  • [22] A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes
    Bender, Christine
    Wiedeman, Alice E.
    Hu, Alex
    Ylescupidez, Alyssa
    Sietsema, William K.
    Herold, Kevan C.
    Griffin, Kurt J.
    Gitelman, Stephen E.
    Long, S. Alice
    SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (746)
  • [23] Rash in a Patient With New-Onset Type 1 Diabetes Mellitus
    Wahba, Amr
    Ogunsakin, Amie
    AACE CLINICAL CASE REPORTS, 2023, 9 (05): : 178 - 179
  • [24] Delayed referral and DKA in new-onset Type 1 diabetes
    White, Mary
    Manski-Nankervis, Jo-Anne
    JOURNAL OF PEDIATRICS, 2022, 244 : 251 - 251
  • [25] Neurocutaneous melanosis presenting with new-onset type 1 diabetes
    Joseph, KR
    Difazio, M
    Spring, S
    Hartman, KR
    Ney, JP
    NEUROLOGY, 2006, 66 (05) : A341 - A341
  • [26] New-Onset Type 1 Diabetes in an Elderly Female on Pembrolizumab
    Bansal, Saurabh
    Saca, Daniel
    Getz, Daniel
    Rab, Asra
    Singhania, Namrata
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2022, 363 (04): : 371 - 372
  • [27] Atezolizumab induced new-onset type 1 diabetes mellitus
    de Carlos, Joaquin
    Zabalza, Lucia
    Garcia, Javier
    Marti, Miguel
    Ayarza-Marien, Xabier
    Yoldi, Jon
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (05) : 1268 - 1270
  • [28] No Effect of the 1α,25-Dihydroxyvitamin D3 on β-Cell Residual Function and Insulin Requirement in Adults With New-Onset Type 1 Diabetes
    Walter, Markus
    Kaupper, Thomas
    Adler, Kerstin
    Foersch, Johannes
    Bonifacio, Ezio
    Ziegler, Anette-G
    DIABETES CARE, 2010, 33 (07) : 1443 - 1448
  • [29] Failure to Preserve β-Cell Function With Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients With New-Onset Type 1 Diabetes
    Gottlieb, Peter A.
    Quinlan, Scott
    Krause-Steinrauf, Heidi
    Greenbaum, Carla J.
    Wilson, Darrell M.
    Rodriguez, Henry
    Schatz, Desmond A.
    Moran, Antoinette M.
    Lachin, John M.
    Skyler, Jay S.
    DIABETES CARE, 2010, 33 (04) : 826 - 832
  • [30] Effect of ingested interferon-α on β-cell function in children with new-onset type 1 diabetes. (vol 32, pg 1250, 2009)
    Rother, K., I
    Brown, R. J.
    Morales, M. M.
    Wright, E.
    Duan, Z.
    Campbell, C.
    Hardin, D. S.
    Popovic, J.
    McEvoy, R. C.
    Harlan, D. M.
    Orlander, P. R.
    Brod, S. A.
    DIABETES CARE, 2009, 32 (09) : 1751 - 1751
12345